AKT1 and cancer: Rapamycin and its derivatives, which specifically inhibit mTOR, induced rapid Akt (Ser473) phosphorylation both in cancer cells and in clinical patient tumors [7], presumably due to inhibition of a mTOR-dependent retrograde signal [12].